/ /

  • linkedin
  • Increase Font
  • Sharebar

    VEP, ERG testing brings objective data to clinical practice

    Diagnostic modality enables earlier disease detection for better patient prognosis

    Take-home message: Recent technologic advances have helped move visual electrophysiological testing into the clinical setting.





    Kansas City, MO—Though electrophysiological testing has been around for decades, until recently, its use has been more common in research centers than in clinical settings.

    I had the privilege of being involved in some of early-generation diagnostics in the 1980s. To be able to benefit from these technologies decades later is exciting. Becoming an early adapter was an easy decision.

    Our practice consists of three physicians in two locations, each equipped with a visual-evoked potential (VEP) and electroretinography (ERG) vision testing system (Diopsys NOVA VEP and ERG Vision Testing System, Diosys Inc.).

    The high-volume, comprehensive practice deals with many different pathologies but has a corneal specialty. The practice also has a high volume of glaucoma patients and sees a significant volume of patients with maculopathy, including age-related macular degeneration (AMD) and diabetic retinopathy.

    Electrophysiological testing has fit seamlessly into the practice. A separate schedule is maintained for ancillary testing, with technicians conducting visual fields and optical coherence tomography (OCT), as well as pattern electroretinography (PERG) and VEP with the system. While scheduling depends on the clinic’s volume on each particular day, the attempt is to bring patients in for testing when there is less stress on the clinic.

    This typically means the patient will be coming in for a separate testing appointment than when he or she is scheduled to see the physician, either earlier that same day or on a prior day. This ensures the physician will have all necessary data when the patient is seen. However, there is no second co-payment for this added visit so the patient need not worry about anything other than fitting the appointment into his or her schedule.

    VEP and PERG

    VEP and PERG are easily performed in an office setting. As objective tests, they do not rely on responses from the patients. As such, they are considerably useful with non-communicative patients, stroke patients, non-English speaking patients, and children.

    In addition, they are excellent for rare cases of malingerers and workman’s compensation claims issues, as the testing provides documented evidence of damage.

    VEP measures the electrical activity of the visual cortex. The amplitude of the signal will be greater or lesser depending on the presence of healthy retinal cells versus the amount of disease present. Latency indicates the amount of time it takes for the signal to reach the visual cortex from the retina.

    Patients are tested with an 85% high contrast and 15% low contrast stimulus. The former is weighted more toward the function of the parvocellular pathway. Abnormal results from high contrast testing can be an indicator of central vision loss. Low-contrast testing is weighted more toward the function of the magnocellular pathway, where abnormal results may be an early indicator of glaucoma.

    PERG focuses on the electrical activity of the retinal ganglion cells rather than the full visual system. ERG concentric stimulus fields protocol is valuable in detecting diseases that have an expected pattern of macular degeneration, whereas the contrast sensitivity protocol is valuable in detecting diseases that affect the retina in a diffuse pattern.

    New Call-to-action


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available


    View Results